Abstract:Pulmonary premature ageing and fibrogenesis as in idiopathic pulmonary fibrosis (IPF) occur with the DNA damage response in lungs deficient of telomerase. The molecular mechanism mediating pulmonary alveolar cell fates remains to be investigated. The present study shows that naturally occurring ageing is associated with the DNA damage response (DDR) and activation of the p53 signalling pathway. Telomerase deficiency induced by telomerase RNA component (TERC) knockout (KO) accelerates not only replicative senescence but also altered differentiation and apoptosis of the pulmonary alveolar stem cells (AEC2) in association with increased innate immune natural killer (NK) cells in TERC KO mice. TERC KO results in increased senescence-associated heterochromatin foci (SAHF) marker HP1γ, p21, p16, and apoptosis-associated cleaved caspase-3 in AEC2. However, additional deficiency of the tumour suppressor p53 in the Trp53−/− allele of the late generation of TERC KO mice attenuates the increased senescent and apoptotic markers significantly. Moreover, p53 deficiency has no significant effect on the increased gene expression of T1α (a marker of terminal differentiated AEC1) in AEC2 of the late generation of TERC KO mice. These findings demonstrate that, in natural ageing or premature ageing accelerated by telomere shortening, pulmonary senescence and IPF develop with alveolar stem cell p53-dependent premature replicative senescence, apoptosis, and p53-independent differentiation, resulting in pulmonary senescence-associated low-grade inflammation (SALI). Our studies indicate a natural ageing-associated molecular mechanism of telomerase deficiency-induced telomere DDR and SALI in pulmonary ageing and IPF.

A Switch-Like Dynamic Mechanism for the Initiation of Replicative Senescence

subset of chromosome ends , leading to propagation of a DNA damage response that induces senescence or cell death (

Selective pericentromeric heterochromatin dismantling caused by TP53 activation during senescence

Telomeric 8-oxo-guanine drives rapid premature senescence in the absence of telomere shortening

Replicative senescence is ATM driven, reversible, and accelerated by hyperactivation of ATM at normoxia

Cell Fate Decision by an Adaptable Molecular Timer of P53

Senescence Reprogramming by MTHFD2 Deficiency Facilitates Tumor Progression

The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo.

A mitochondria-regulated p53-CCF circuit integrates genome integrity with inflammation

Mitochondrion-processed TERC regulates senescence without affecting telomerase activities

Linked regulation of genome integrity and senescence-associated inflammation by p53

Early telomerase inactivation accelerates aging independently of telomere length

A DNA damage checkpoint response in telomere-initiated senescence

Mitogen-Activated Protein Kinase P38 Defines The Common Senescence-Signalling Pathway

Pulmonary Alveolar Stem Cell Senescence, Apoptosis, and Differentiation by p53-Dependent and -Independent Mechanisms in Telomerase-Deficient Mice

Looping-out Mechanism for Resolution of Replicative Stress at Telomeres.

Unveiling E2F4, TEAD1 and AP-1 as regulatory transcription factors of the replicative senescence program by multi-omics analysis

Telomerase-null survivor screening identifies novel telomere recombination regulators.

Replicative senescence revisited

Transient Induction of Telomerase Expression Mediates Senescence and Reduces Tumorigenesis in Primary Fibroblasts.

Mechanotransduction is the Janus-faced regulator of cell aging